Journal Information
Vol. 108. Issue 1.
Pages 75-76 (January - February 2017)
Vol. 108. Issue 1.
Pages 75-76 (January - February 2017)
Case and Research Letter
DOI: 10.1016/j.adengl.2016.11.009
Full text access
Bullous Morphea: Description of a New Case and Discussion of Etiologic and Pathogenic Factors in Bulla Formation
Un nuevo caso de morfea ampollosa y discusión de los factores etiopatogénicos en la formación de las ampollas
Visits
...
S. Sánchez-Pérez
Corresponding author
ssanchez.derma@gmail.com

Corresponding author.
, I. Escandell-González, M.I. Pinazo-Canales, E. Jordá-Cuevas
Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text
To the Editor:

Bullous morphea is a rare form of localized scleroderma. Since the description of the first case, numerous theories have been put forward on the origin of the blisters, but the actual mechanism by which they develop remains unclear.

Our patient, a 63-year-old woman, presented 2 lesions that had arisen some months earlier, localized symmetrically in the pretibial regions (Fig. 1). The lesions had an atrophic appearance, an erythematous base, and a central blister that contained a blood-stained fluid. The patient described no history of trauma.

Figure 1.

Bilateral atrophic plaques with overlying blisters.

(0.08MB).

Biopsy showed subepidermal separation with preservation of the basal layer. A mild inflammatory component and collagen fibrils were observed in the superficial dermis, but extensive sclerosis with a dense lymphocytic infiltrate was found in the reticular dermis and subcutaneous cellular tissue, though with no vasculitis or significant presence of eosinophils (Fig. 2). No lymphangiectasia was observed after staining with hematoxylin-eosin or D2-40 (Fig. 3). The findings were compatible with a diagnosis of bullous morphea. Blood tests were within normal limits and Borrelia serology was negative. Topical therapy with betamethasone and fusidic acid was started, leading to resolution of the blisters, but the sclerotic plaques deteriorated and systemic treatment was therefore commenced with oral methotrexate, achieving a good response.

Figure 2.

Subepidermal blister with preservation of the basal layer. Hematoxylin and eosin, original magnification ×20.

(0.27MB).
Figure 3.

Lymph vessels of normal caliber. D2-40, original magnification ×10.

(0.22MB).

Bullous morphea is a rare form of localized scleroderma.1 The first case was described by Morrow in 1896.2 Since that time, numerous theories on its origin have been proposed.3–5

The most widely accepted theory on the origin of the blisters has been lymphatic obstruction due to lymphangiectasia caused by the underlying sclerotic changes.1,3,5,6 However, not all lesions of bullous morphea present lymphangiectasia on histology, nor do all cases of scleroderma with lymphangiectasia present blisters.1,4,7

Local trauma may be another etiologic and pathogenic factor, given the hemorrhagic content of some blisters and their frequent localization in areas of friction such as the legs and intertriginous areas.1,7,8 No history of trauma was detected in our patient, but some findings, such as the localization of the blisters in the pretibial region, the blood-stained content, and the absence of other etiologic and pathogenic factors, could suggest that unperceived trauma may have played a role in the formation of the lesions.

Cases have been reported in which blisters developed as an isotopic or isomorphic response on residual lesions of herpes zoster or on the scars of previous surgery, trauma, injections, or radiation.1,6,8 Some authors have suggested that eosinophils may play a role in this disease,5 while other postulate reactive oxygen species as a possible causative factor.9

We have also found cases with 2 or more coexisting bullous diseases, such as pemphigus vulgaris, epidermolysis bullosa, and porphyria cutanea tarda; these diseases were ruled out in our patient.3,10 Likewise, scleroderma-like changes are recognized in patients with graft-versus-host disease, and the appearance of blisters on these lesions has also been reported.8

The diagnosis of bullous morphea requires a detailed medical history, full physical examination, skin biopsy with direct immunofluorescence, and blood tests including serology for Borrelia (typically negative) and autoimmunity.3–5

Histology reveals a greater or lesser degree of epidermal atrophy with flattening of the crests. The blisters are subepidermal, have a blood-stained content, and may be associated with edema of the papillary dermis.1,4,5 In the reticular dermis there are prominent thick bundles of hyalinized collagen that destroy the adnexal structures.5

The main differential diagnosis of morphea is with lichen sclerosus et atrophicus, and the 2 diseases can coexist in some patients. In contrast to lichen sclerosus et atrophicus, the basal layer and the elastic fibers of the reticular dermis are unaffected in bullous morphea, which also does not show follicular plugs.4,7

Numerous therapeutic strategies have been used, including phototherapy, topical and systemic corticosteroids, topical vitamin D analogs, antimalarials, various immunosuppressant agents, systemic retinoids, certain antibiotics, colchicine, and phenytoin. Also, isolated cases have been treated with extracorporeal photophoresis, N-acetylcysteine, imiquimod, sulfasalazine, or skin grafts, with varying results.3–5,9

In conclusion, we have presented a case of bullous morphea in which lymphangiectasia was not detected on histology; this, together with the pretibial site of the lesions and their blood-stained content, leads us to speculate that unperceived trauma may have been the cause of the blisters in this case. Regarding treatment, it would appear reasonable to adopt an approach similar to that for nonbullous forms of morphea, starting with topical agents (corticosteroids, vitamin D analogs) or phototherapy, and advancing to systemic treatments such as methotrexate if no response is observed.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References
[1]
A. Fernández Flores, M. Gatica Torres, F. Tinoco Fragoso, F. García Hidalgo, L. García Hidalgo, E. Monroy, et al.
Three cases of bullous morphea: Histopathologic findings with implications regarding pathogenesis.
J Cutan Pathol, 42 (2015), pp. 144-149
[2]
P.A. Morrow.
A case of symmetrical morphea attended with the formation of bullae and extensive ulceration.
J Cutan Genito-Urin Dis, 14 (1896), pp. 419-427
[3]
A. Rencic, S. Goyal, M. Mofid, F. Wigley, H.C. Nousari.
Bullous lesions in scleroderma.
Int J Dermatol, 41 (2002), pp. 335-339
[4]
S. Yasar, C.T. Mumcuoglu, Z.A. Serdar, P. Gunes.
A case of lichen sclerosus et atrophicus accompanying bullous morphea.
Ann Dermatol, 23 (2011), pp. 354-359
[5]
M.S. Daoud, W.P. Su, K.M. Leiferman, C. Perniciaro.
Bullous morphea: Clinical, pathologic, and immunopathologic evaluation of thirteen cases.
J Am Acad Dermatol, 30 (1994), pp. 937-943
[6]
T. Qu, K. Fang.
Bullous morphea arising at the site of a healed herpes zoster.
J Dermatol, 41 (2014), pp. 553-554
[7]
M. Kavala, I. Zindaci, C. Demirkesen, E.K. Beyhan, Z. Turkoglu.
Intertriginous bullous morphea: A clue for the pathogenesis?.
Indian J Dermatol Venereol Leprol, 73 (2007), pp. 262-264
[8]
D. Grabell, C. Hsieh, R. Andrew, K. Martires, A. Kim, R. Vasquez, et al.
The role of skin trauma in the distribution of morphea lesions: A cross-sectional survey of the morphea in adults and children cohort IV.
J Am Acad Dermatol, 71 (2014), pp. 493-498
[9]
E. Rosato, M.L. Veneziano, A. di Mario, I. Molinaro, S. Pisarri, F. Salsano.
Ulcers caused by bullous morphea: Successful therapy with N-acetylcysteine and topical wound care.
Int J Immunopathol Pharmacol, 26 (2013), pp. 259-262
[10]
J.E. Bernstein, M. Nedenica, K. Soltani.
Coexistence of localized bullous pemphigoid, morphea, and subcorneal pustulosis.
Arch Dermatol, 117 (1981), pp. 725-727

Please cite this article as: Sánchez-Pérez S, Escandell-González I, Pinazo-Canales MI, Jordá-Cuevas E. Un nuevo caso de morfea ampollosa y discusión de los factores etiopatogénicos en la formación de las ampollas. Actas Dermosifiliogr. 2017;108:75–76.

Copyright © 2016. Elsevier España, S.L.U. and AEDV
Idiomas
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

Article options
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
  • Additional material
Tools
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.